Search

Financial results - DAR AL DAWA PHARMA SRL

0.00
Financial Summary - Dar Al Dawa Pharma Srl
Unique identification code: 8630605
Registration number: J40/6082/1996
Nace: 4646
Sales - Ron
-
Net Profit - Ron
-75.308
Employees
Open Account
Company Dar Al Dawa Pharma Srl with Fiscal Code 8630605 recorded a turnover of 2024 of - , with a net profit of -75.308 and having an average number of employees of - . The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Dar Al Dawa Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 848.603 0 0 0 0 0 0 0 0 0
Total Income - EUR 850.335 45.449 170.338 14.115 22.025 119.419 32.247 11.637 72.384 31.530
Total Expenses - EUR 392.187 234.680 10.389 92.994 87.055 3.483 267.622 103.936 40.153 106.838
Gross Profit/Loss - EUR 458.147 -189.232 159.949 -78.879 -65.030 115.936 -235.375 -92.299 32.231 -75.308
Net Profit/Loss - EUR 453.438 -189.232 154.864 -79.135 -65.227 112.353 -235.513 -92.299 27.064 -75.308
Employees 10 5 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Dar Al Dawa Pharma Srl

Rating financiar

Financial Rating -
DAR AL DAWA PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Dar Al Dawa Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dar Al Dawa Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Dar Al Dawa Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dar Al Dawa Pharma Srl - CUI 8630605

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 136.102 132.288 130.050 252.274 247.389 242.699 237.317 238.053 237.331 236.005
Current Assets 655.818 600.446 595.606 584.659 589.778 582.550 492.526 512.563 486.615 515.309
Inventories 36 36 35 35 34 33 33 0 0 0
Receivables 255.015 254.521 258.283 245.268 240.702 236.216 128.890 136.363 128.898 128.082
Cash 400.766 345.889 8.870 11.556 349.042 1.172 33 33 120 387.228
Shareholders Funds -1.167.588 -1.344.912 -1.167.289 -1.088.995 -1.133.133 -999.298 -1.212.648 -1.308.709 -1.277.676 -1.345.843
Social Capital 652 646 635 623 611 600 586 588 586 583
Debts 1.960.482 2.078.082 1.892.945 1.925.928 1.970.299 1.824.546 1.942.490 2.059.325 2.001.622 2.097.157
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 515.309 euro in 2024 which includes Inventories of 0 euro, Receivables of 128.082 euro and cash availability of 387.228 euro.
The company's Equity was valued at -1.345.843 euro, while total Liabilities amounted to 2.097.157 euro. Equity decreased by -75.308 euro, from -1.277.676 euro in 2023, to -1.345.843 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Dar Al Dawa Pharma Srl

Comments - Dar Al Dawa Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.